Wednesday, April 15th 2020 at 10:45am UTC ONTRUZANT® is Samsung Bioepis’ first oncology biosimilar available in the United States INCHEON,…
Thursday, February 6th 2020 at 9:00pm UTC Webcast and Conference Call Today at 4:30 p.m. ET Positive results from part…
Thursday, April 30th 2020 at 9:30pm UTC ALBANY, N.Y.–(BUSINESS WIRE)– AMRI today announced its ongoing commitment to do its part…
Tuesday, March 3rd 2020 at 1:00pm UTC SALT LAKE CITY–(BUSINESS WIRE)– PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and…
Thursday, May 21st 2020 at 11:03am UTC Executives from Alnylam and Pfizer to discuss how innovative oncology and specialty medicines…
Wednesday, July 8th 2020 at 11:00am UTC LITTLETON, Mass.–(BUSINESS WIRE)– Mevion Medical Systems announced today that patient treatment has commenced…
Wednesday, July 8th 2020 at 11:01am UTC SANTA CLARA, Calif.–(BUSINESS WIRE)– Filtricine today announced the start of its first human…
Wednesday, July 8th 2020 at 1:44pm UTC Cohorts of younger adults (n=300) and older adults (n=300) in Phase 2 study…
Wednesday, July 8th 2020 at 8:15pm UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing…
Wednesday, July 8th 2020 at 8:00pm UTC PASADENA, Calif.–(BUSINESS WIRE)– Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will…